ACC 2006

ARMYDA-3 Study Shows Statins Reduce Atrial Fibrillation After Cardiac Surgery

Germano Di Sciascio
Germano Di Sciascio, Campus Biomedico University of Rome
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta
The anti-inflammatory action of statins may be causing yet another benefit in heart patients: a reduction of atrial fibrillation risk after surgery. The ARMYDA-3 study enrolled patients scheduled for coronary artery bypass grafting, or valve surgery and randomised them to receive 40 mg of atorvastatin or placebo. The results showed a significant reduction of AF in the statin-treated group.

Similar Interviews

  • Audio Journal of Cardiovascular Medicine: May 2006 - In the company of James Tcheng
  • Annual Meeting of the American College of Cardiology March 11-14, 2006, Atlanta: Atheroma Reversal, Statins for Acute Coronary Syndromes, Targeting

  • Warfarin Trumps Platelet Agents in Atrial Fibrilation
  • For atrial fibrillation, oral anti-coagulation remains the treatment of choice despite the potential of an anti-platelet regimen based on aspirin

  • Catheter Ablation: Better than Multi Drug Therapy for Paroxysmal Atrial Fibrillation
  • Carlo Pappone, San Raffaele University Hospital, Milan American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta The use of circumferential

    Post a comment

    Subscribe to Audio Medica Podcast